Stevanato Group S.p.A. (STVN)

Stevanato Group S.p.A. stock price today, ATLAS forecast and fair value

Healthcare · Medical Instruments & Supplies · NYSE

$19.64▼ -1.21%

Prices as of Oct 27, 2026 · USD

ATLAS fair value

$19.76

Close to fair value · 1% discount

Chance of rising in 1 month

50%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Stevanato Group S.p.A. in ATLAS

ATLAS's own quantitative analysis, all in one place.

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
See everything included
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.

On Stevanato Group S.p.A.

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.

And for you

  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.
Get started →

Plans from €3.99 a month.

ATLAS estimates Stevanato Group S.p.A.'s fair value at about $19.76 per share (reasonable range: $17.42 to $22.19). At $19.64, the stock trades within 8% of that figure: close to fair value.

It is calculated with valuation multiples of comparable companies. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.

ATLAS's model gives Stevanato Group S.p.A. a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between $18.51 and $20.87; in 9 out of 10, between $16.64 and $23.22. Estimated annual volatility is 28%.

Price, last 12 months (weekly close)

Stevanato Group S.p.A. (STVN) — Price, last 12 months (weekly close)Oct 24, 2025: $26.11. Oct 27, 2026: $19.64. ▼Fair value $19.76$26.11$13.43Oct 24, 2025Oct 27, 2026

Key numbers

Market cap
$5.5B
P/E ratio
36.5
Dividend yield
0.32%
52-week high
$27.00
52-week low
$12.89
Revenue (12 months)
$1.4B
Revenue growth (YoY)
+7.4%
Earnings growth (YoY)
+18.6%
Gross margin
29.0%
Operating margin
16.8%
Net margin
11.8%
Return on equity
9.1%
Free cash flow (12 months)
$-118M
Beta
0.75

What this means

These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Stevanato Group S.p.A. sits close to fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.

Over the last 52 weeks STVN has traded between $12.89 and $27.00. Today it is 27.3% below that high and 52% above its low.

On the business: revenue grew 7.4% year over year; net margin is 11.8%; it trades at 36.5 times earnings.

Its beta is 0.75: it tends to move less than the market.

About the company

Stevanato Group S.p.A. is an Italy-based healthcare company that provides integrated solutions for the pharmaceutical, biotechnology, and life sciences industries.

Want to see everything about Stevanato Group S.p.A.?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What is Stevanato Group S.p.A. (STVN) fair value?

About $19.76 per share according to ATLAS (reasonable range: $17.42 to $22.19). With the stock at $19.64, it is close to that value.

What is the chance STVN goes up next month?

50%: close to a coin flip. In half of the simulated outcomes, STVN ends the month between $18.51 and $20.87.

How big is Stevanato Group S.p.A. and what is its P/E ratio?

Stevanato Group S.p.A.'s market capitalization is $5.5B. Its price-to-earnings (P/E) ratio is 36.5: you pay $36.5 for each $1 of yearly earnings.

Does Stevanato Group S.p.A. pay a dividend?

Yes. STVN's current dividend yield is 0.32% at today's price ($19.64).

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer

ATLAS Signals

ATLAS Signals, every week

The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.

By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy